Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CISCO

Cisco has had a dedicated Healthcare team offering guidance on Information and Communications Technology (ICT) solutions into the NHS since 1998, a fourteen year period that has seen significant changes in the UK Healthcare environment. Most recently, the Coalition Government has embarked upon one of the most transformational programmes the NHS has ever seen. Cisco believes that a significant enabler for the proposed reforms is the accelerated deployment of technology to offer business and service transformation. We work with our partners to address specific business issues such as productivity, reform and reconfiguration by offering innovative solutions supporting new models of care through mobile working and collaboration.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

CISCO
9 New Square, Bedfont Lakes, Feltham, Middlesex, TW14 8HA, UK
+44 (0)20 8824 1000
Contact CISCO
Website

 Latest Content from PMHub 

07 Good Pharma

White Papers and Resources | January 3, 2014 | Havas Lynx

Better for patients, better for business

06 Our Opportunity to Rethink the Health Experience

White Papers and Resources | January 3, 2014 | Havas Lynx

Our point of view

05 Social Media: A Health Hazard?

White Papers and Resources | January 3, 2014 | Havas Lynx

The case to embrace going social

Creating a Lifeline to the New Digital User

White Papers and Resources | January 3, 2014 | Havas Lynx

Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...

Warehousing of HCV patients reaches new high

White Papers and Resources | December 19, 2013 | Inizio

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Brand leaders in RA will lose market share, predict rheumatologists

White Papers and Resources | December 19, 2013 | Inizio

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

Removing the Roadblocks to Effective Patient Treatment

White Papers and Resources | November 22, 2013 | Inizio

How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...

Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

White Papers and Resources | November 22, 2013 | Inizio

Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...

The Difficulties of Living with Depression Don’t End with the Illness Itself

White Papers and Resources | November 22, 2013 | Inizio

This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.

Patient Power: Too Much of a Good Thing?

White Papers and Resources | November 22, 2013 | Inizio

Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding